Elixpharmasp. z o.o.

Wholesale of pharmaceutical goods

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2025-07-25
Share capital
5 000,00 PLN
Activity description

Elixpharma creates modern dietary supplements based on natural ingredients and knowledge of nutrition, microbiology and human physiology. Its range includes ElixSymbio for the intestinal barrier and microbiome, ElixVia for the nervous system, ElixHepato for liver function and digestion, ElixGluco for glucose metabolism, and ElixADEK with vitamins A, D, E and K.

Registered address
Boryszewska 44A/26, 09-410 Płock, Poland
Website
elixpharma.plWebsite active
Email
Phone
Social media
Electronic delivery address
AE:PL-93062-50100-VJIEJ-28

Financials

Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2025.

Results vs industry

Revenue
This companyUSD 37.27kMedianUSD 874.80kAverageUSD 20.30m
Net profit
This companyUSD 11.81kMedianUSD 28.22kAverageUSD 816.54k
Operating costs
This companyUSD 24.29kMedianUSD 805.63kAverageUSD 19.09m
Assets
This companyUSD 21.27kMedianUSD 541.73kAverageUSD 10.95m

Industry

Bank accounts

Registered as a VAT taxpayer on 2025-08-01. Active

  • Bank spółdzielczy
    Bank spółdzielczy
    75 9038 1014 2606 8888 2000 0010
  • Bank spółdzielczy
    Bank spółdzielczy
    20 9038 1014 2606 8888 2000 0030

Debt

No entries in the National Debtors Register (KRZ). No proceedings in KRZ

Public aid

No public aid cases recorded in the last 10 years.

Tenders

No recorded participation in tenders.

Authorized Representatives

Dominik Bado – President of the Management Board

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
Dominik Bado (27)
100$1,350.62100%

Beneficial owners

Person

Competitors

Name
Food SectorP.S.A.
Biopharmaciasp. z o.o.
NutrisleP.S.A.
Pharmbiopolsp. z o.o.
Mineral Guard Europesp. z o.o.
Terezia Polskasp. z o.o.
Leenlife PharmaS.A.
Lifepointone.Vetsp. z o.o.
Medyczniesp. z o.o.
Edge Pharmasp. z o.o.

FAQ

Last updated: 2026-10-07